B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Cd52 Antigen

98 PubMed studies analyzed ยท 1 RCTs ยท Evidence Score: 46.9

Research Domains

Cd52 Antigen has been studied across 11 research domains including ๐Ÿ”ฌ Oncology, ๐Ÿ›ก๏ธ Immunity, ๐Ÿ˜ด Sleep, ๐Ÿซ˜ Kidney, ๐Ÿ”ฌ Inflammation. The primary research focus is ๐Ÿ”ฌ Oncology with 72% of studies addressing this area.

Loading evidence profile...

This evidence profile for Cd52 Antigen is generated deterministically from 98 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). ยฉ 2026 Organiq Sweden AB.